429 related articles for article (PubMed ID: 29989066)
1. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
Yu L; Zhao J; Gao L
Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
[TBL] [Abstract][Full Text] [Related]
2. Drug repositioning based on triangularly balanced structure for tissue-specific diseases in incomplete interactome.
Yu L; Zhao J; Gao L
Artif Intell Med; 2017 Mar; 77():53-63. PubMed ID: 28545612
[TBL] [Abstract][Full Text] [Related]
3. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.
Chen H; Zhang Z
Biomed Res Int; 2015; 2015():406463. PubMed ID: 25789319
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Novel Drugs for Hepatocellular Carcinoma Based on Multi-Source Random Walk.
Yu L; Su R; Wang B; Zhang L; Zou Y; Zhang J; Gao L
IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(4):966-977. PubMed ID: 27076463
[TBL] [Abstract][Full Text] [Related]
5. Drug repositioning based on the target microRNAs using bilateral-inductive matrix completion.
Deepthi K; Jereesh AS
Mol Genet Genomics; 2020 Sep; 295(5):1305-1314. PubMed ID: 32583015
[TBL] [Abstract][Full Text] [Related]
6. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
7. A computational method for drug repositioning using publicly available gene expression data.
Shabana KM; Abdul Nazeer KA; Pradhan M; Palakal M
BMC Bioinformatics; 2015; 16 Suppl 17(Suppl 17):S5. PubMed ID: 26679199
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
Wang YW; Zhang W; Ma R
Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
[TBL] [Abstract][Full Text] [Related]
9. Predicting miRNA-disease association from heterogeneous information network with GraRep embedding model.
Ji BY; You ZH; Cheng L; Zhou JR; Alghazzawi D; Li LP
Sci Rep; 2020 Apr; 10(1):6658. PubMed ID: 32313121
[TBL] [Abstract][Full Text] [Related]
10. NEMPD: a network embedding-based method for predicting miRNA-disease associations by preserving behavior and attribute information.
Ji BY; You ZH; Chen ZH; Wong L; Yi HC
BMC Bioinformatics; 2020 Sep; 21(1):401. PubMed ID: 32912137
[TBL] [Abstract][Full Text] [Related]
11. Identification of associations between small molecule drugs and miRNAs based on functional similarity.
Wang J; Meng F; Dai E; Yang F; Wang S; Chen X; Yang L; Wang Y; Jiang W
Oncotarget; 2016 Jun; 7(25):38658-38669. PubMed ID: 27232942
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
13. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
14. RWRMDA: predicting novel human microRNA-disease associations.
Chen X; Liu MX; Yan GY
Mol Biosyst; 2012 Oct; 8(10):2792-8. PubMed ID: 22875290
[TBL] [Abstract][Full Text] [Related]
15. Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients.
Xu Y; Lin S; Zhao H; Wang J; Zhang C; Dong Q; Hu C; Desi S; Wang L; Xu Y
Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466383
[TBL] [Abstract][Full Text] [Related]
16. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
Firoozbakht F; Rezaeian I; Rueda L; Ngom A
BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
[TBL] [Abstract][Full Text] [Related]
17. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
18. Reconstruction of temporal activity of microRNAs from gene expression data in breast cancer cell line.
Jayavelu ND; Bar N
BMC Genomics; 2015 Dec; 16():1077. PubMed ID: 26763900
[TBL] [Abstract][Full Text] [Related]
19. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
20. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
